Paper23331
Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
Goldsmith LA. Exp Cell Biol, 1978. Cited by 29 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). Papers, record 23331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acid Metabolism, Inborn Errors | Major topic |
| Eye Diseases | Major topic |
| Skin Diseases | Major topic |
| Tyrosine | Major topic |
| Tyrosine Transaminase | Major topic |
| Animals | |
| Child | |
| Crystallization | |
| Disease Models, Animal | |
| Female | |
| Hemolysis | |
| Heterozygote | |
| Humans | |
| In Vitro Techniques | |
| Infant | |
| Infant, Newborn | |
| Intellectual Disability | |
| Liver | |
| Lysosomes | |
| Male | |
| Rats | |
| Syndrome |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36471409 | The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III). | Orphanet J Rare Dis | 2022 | https://conductscience.org/library/papers/36471409 | PubMed |
| 33578033 | Amino acid metabolism and autophagy in skeletal development and homeostasis. | Bone | 2021 | https://conductscience.org/library/papers/33578033 | PubMed |
| 29417439 | Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats. | Neurotox Res | 2018 | https://conductscience.org/library/papers/29417439 | PubMed |
| 28315992 | Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II. | Metab Brain Dis | 2017 | https://conductscience.org/library/papers/28315992 | PubMed |
| 6117279 | Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II. | Biochem Genet | 1981 | https://conductscience.org/library/papers/6117279 | PubMed |
| 3516355 | Metabolic syndromes with dermatologic manifestations. | Clin Rev Allergy | 1986 | https://conductscience.org/library/papers/3516355 | PubMed |
| 1350979 | Maternal tyrosinaemia II: management and successful outcome. | Eur J Pediatr | 1992 | https://conductscience.org/library/papers/1350979 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23331
GET https://conductscience.org/api/papers/v1/23331/authors